RxDoctor Payments Data

Catherine Mintzer

Internal Medicine · Cambridge, MANPI 1013905652

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $986 and has fallen 97.6% since, to $24 in 2022.

$1,029in general payments, 2019–2025

Across 54 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$180
  • Johnson & Johnson$83
  • Novo Nordisk$81
  • Boehringer Ingelheim$73
  • AbbVie$71
  • AstraZeneca$57
  • plus $484 from 16 others

What the payments were for

  • Food & beverage$1,029100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,029 in reported general payments places this provider in the 85th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts →

Other internal medicine in Cambridge

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →